Written Answer to Unanswered Oral Question

Protecting Consumers against False Claims by Health Supplement Companies

Speakers

Summary

This question concerns the regulatory framework for protecting consumers from false health claims and the efforts to remove unsafe dietary supplements from the market. Dr Wan Rizal asked about balancing health protection with consumer choice and the use of import alerts for companies producing supplements or sports nutrition. Minister for Health Ong Ye Kung explained that supplements do not require pre-market approval but are prohibited from containing potent medicinal ingredients or claiming to treat diseases. He highlighted the Health Sciences Authority’s post-market surveillance, product recalls, and the publication of safety guidelines to ensure industry compliance. To empower consumers, the Ministry issues press releases on unsafe products and provides educational advisories to support informed decision-making regarding supplement consumption.

Transcript

61 Dr Wan Rizal asked the Minister for Health given the recent case where a health supplement company is fined for making false cancer cure claims, how does the Ministry balance public health protection and unnecessary restriction of consumer choice.

62 Dr Wan Rizal asked the Minister for Health whether the Ministry is currently working with other agencies to issue import alerts for companies operating in dietary supplements, natural health and sports nutrition so as to timeously remove any unsafe supplement product.

Mr Ong Ye Kung: Health supplements are products which are marketed as enhancing a person’s well-being, for example, by making claims, such as "for vitality", "supports joint function". As these products are not meant to prevent, treat or cure diseases, the supplements can be imported or placed on the market for sale to consumers, without HSA’s approval.

To protect public safety, HSA prohibits the addition of potent medicinal ingredients in health supplements. Any claims that these products can prevent, treat or cure any medical conditions, such as diabetes, hypertension and cancer, are also prohibited. HSA administers a post-market surveillance programme to monitor the safety of health supplements and to initiate product recalls when necessary.

HSA publishes guidelines on the safety and quality standards to facilitate industry’s introduction of safe and quality products in the market. These include information, such as disallowed ingredients and claims, toxic heavy metal and microbial limits.

To inform the public, HSA issues press releases on unsafe health supplements and false or exaggerated claims. Consumer guides and advisories on the HSA and HealthHub websites enable consumers to make better decisions, should they choose to purchase or consume health supplements.